Promoter holding
64.27%
CI
Curadev Immunology Llp - Due diligence report
A 360° intelligence report on Curadev Immunology Llp: trust score, financial health, credit view, compliance, directors, growth and distress…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Curadev Immunology Llp — 360° Intelligence Report
Generated from MCA filings & public records82/100
Trust Score
Low Risk
Curadev Immunology Llp is assessed as Low Risk with a Trust Score of 82/100. Curadev Immunology Llp is an active limited liability partnership incorporated in 2026. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and an unassessed financial risk profile.
Report generated on 26 Sep 2026 from the latest processed filings. Curadev Immunology Llp snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
82/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
90/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreNo Data
N/A
No processed financial statements available yet.
Credit Risk ScoreNo Data
N/A
Financial statements needed for a credit view.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
No processed financialsFinancial statements are not yet processed for this company. Trend analysis will appear once filings are available.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: N/A No Data
- Financial statements needed for a credit view.
Charges position: 0 open (-) · 0 satisfied (-).
Compliance Score: 90/100 Low Risk
- Company status is Active as per MCA.
- No balance-sheet filing date on record.
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| Manish Tandon | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Arjun Surya | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
06
Ownership & Group Intelligence
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth N/A · Distress 90
Growth signals & trust indicators
Very young company (under 3 years).
Financials unavailable - score leans on compliance and governance signals.
Distress signals & risk flags
No critical warning flags detected in the available data.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence88/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- No distress signals on file.
- No financials on record - ask for audited statements.
Banker assessment77/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- No filed financials - rely on banking statements and GST data.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
Investor view62/100
Mixed indicators
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Request management accounts - public filings insufficient.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 3 events01 Apr 2026
Incorporated
Registered with Roc Uttar Pradesh Ii
Director appointed
Manish Tandon (Designated Partner)
Director appointed
Arjun Surya (Designated Partner)
10
Key Observations
Auto-generated from the data aboveCompliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
Peer companies will appear here as our matching engine processes this industry.
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Curadev Immunology Llp before audits and certifications: compliance score 90/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Curadev Immunology Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Curadev Immunology Llp - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 82/100, distress signals and MSME payment-delay disclosures - know whether Curadev Immunology Llp pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Curadev Immunology Llp - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Curadev Immunology Llp an active company?
Curadev Immunology Llp has MCA status “Active” with a compliance score of 90/100 (Low Risk).
Is Curadev Immunology Llp financially healthy?
Processed financial statements are not yet available for Curadev Immunology Llp, so its financial health is unassessed.
Should I do business with Curadev Immunology Llp?
Its overall Trust Score is 82/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Curadev Immunology Llp?
See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.
Does Curadev Immunology Llp have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Curadev Immunology Llp up to date with its ROC filings?
No balance-sheet filing date on record. Overall compliance score: 90/100 (Low Risk).
Is it risky to lend to Curadev Immunology Llp?
Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
